These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14331177)

  • 1. NEUTRALIZING ANTIBODIES AGAINST COXSACKIE A21 VIRUS (COE VIRUS) AMONG PERSONS IN SENDAI.
    NIITU Y; HANDA T
    Sci Rep Res Inst Tohoku Univ Med; 1965 Mar; 12():86-9. PubMed ID: 14331177
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE FREQUENCY OF NEUTRALIZING ANTIBODIES FOR COXSACKIE B VIRUSES IN THE ADULT POPULATION OF COASTAL REGIONS OF TUSCANY].
    SANTOPADRE G; BENDINELLI M; RUSCHI A
    Riv Ist Sieroter Ital; 1963; 38():226-31. PubMed ID: 14091699
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research, in a sample of the population of Asmara (Eritrea), on antibodies neutralizing some types of enterovirus (poliovirus 1, 2 and 3; Coxsackie virus B 1 to B 5; ECHO virus 9, 11, and 12)].
    Sebastiani A; Taglieri G; Balestrieri A
    Acta Med Ital Med Trop Subtrop Gastroenterol; 1965; 20(4):29-33. PubMed ID: 5181044
    [No Abstract]   [Full Text] [Related]  

  • 4. NEUTRALIZING ANTIBODIES IN HUMAN SERA AGAINST ECHO 4, 6, 9, AND COXSACKIE A 7 VIRUSES.
    NIKOLAYEV VP
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():516-20. PubMed ID: 14238950
    [No Abstract]   [Full Text] [Related]  

  • 5. COXSACKIE B1 VIRUS ASSOCIATED WITH ATYPICAL PNEUMONIA FOUND IN A MASS CHEST X-RAY SURVEY AMONG SCHOOL CHILDREN IN SENDAI IN 1960.
    NIITU Y
    Sci Rep Res Inst Tohoku Univ Med; 1965 Mar; 12():75-85. PubMed ID: 14331176
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on Coxsackie virus infection in Hungary. II. Studies on neutralising antibodies against fourteen different types of Coxsackie virus in individual and pooled human sera.
    BALAZS V; PINTER M
    Acta Microbiol Acad Sci Hung; 1955; 2(4):429-33. PubMed ID: 13248483
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application.
    MELNICK JL; LEDINKO N
    J Exp Med; 1950 Nov; 92(5):463-82. PubMed ID: 14778925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of coxsackievirus A21 neutralizing antibodies in Yamagata, Japan, between 1976 and 2019; coxsackievirus A21 has rarely affected young children.
    Tanaka W; Komabayashi K; Ikeda Y; Aoki Y; Itagaki T; Mizuta K
    J Med Virol; 2022 Jun; 94(6):2877-2881. PubMed ID: 34811773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLINICAL PARALYTIC POLIOMYELITIS DUE TO COXSACKIE VIRUS GROUP B, TYPE 1.
    TSUBOSAKI H; ONO Y
    Tokushima J Exp Med; 1963 Feb; 10():228-31. PubMed ID: 14049845
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic identification of Coxsackie A21 virus with Coe virus.
    SCHMIDT NJ; FOX VL; LENNETTE EH
    Proc Soc Exp Biol Med; 1961 May; 107():63-5. PubMed ID: 13748037
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDY ON A RECENT EPIDEMIC OF GROUP B COXSACKIE VIRUS INFECTION].
    TERADA M
    Nihon Densenbyo Gakkai Zasshi; 1964 Jul; 38():115-23. PubMed ID: 14195655
    [No Abstract]   [Full Text] [Related]  

  • 12. Coxsackie virus infection in association with heart affection in man.
    Petrovicová A; Cervenka J; Egnerová A
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):251-7. PubMed ID: 2824602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of Coxsackie virus neutralizing antibodies in domestic animals].
    BOSSE R
    Z Hyg Infektionskr; 1958; 144(5):454-9. PubMed ID: 13558312
    [No Abstract]   [Full Text] [Related]  

  • 14. RESPONSE OF VOLUNTEERS TO INOCULATION WITH HEMAGGLUTININ-POSITIVE AND HEMAGGLUTININ-NEGATIVE VARIANTS OF COXSACKIE A21 VIRUS.
    LANG DJ; CATE TR; COUCH RB; KNIGHT V; JOHNSON KM
    J Clin Invest; 1965 Jul; 44(7):1125-31. PubMed ID: 14328389
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemic infection with Coxsackie virus, group B, type 5. 2. Virus excretion and neutralizing antibody response.
    CHIN TD; LEHAN PH; RUBIN H; WENNER HA
    Am J Hyg; 1958 May; 67(3):321-30. PubMed ID: 13533406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Presence of neutralizing antibodies against Coxsackie virus and Echoviruses 9,11 and 12 in subjects of Accra (Ghana)].
    Russo V; D'Arrigo C; Rosei L
    Arch Ital Sci Med Trop Parassitol; 1968; 49(5):145-52. PubMed ID: 5715929
    [No Abstract]   [Full Text] [Related]  

  • 17. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
    Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute respiratory illness associated with Coxsackie B4 virus in children.
    Ray CG; Plexico KL; Wenner HA; Chin TD
    Pediatrics; 1967 Feb; 39(2):220-6. PubMed ID: 6017958
    [No Abstract]   [Full Text] [Related]  

  • 19. [Western blotting in the serologic diagnosis of enterovirus infections. II. Detection of coxsackievirus antibodies in the sera of patients with suspected enterovirus infection and in paired specimens of sera and saliva].
    Petrovicová A; Bopegamage S; Tietzová J; Stará M
    Epidemiol Mikrobiol Imunol; 1997 May; 46(2):51-4. PubMed ID: 9264793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A seroepidemiological study on illnesses resembling epidemic myalgia in relation to coxsackie virus group B infection.
    Kusama T
    Fukushima J Med Sci; 1969 Aug; 16(1):1-24. PubMed ID: 5380737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.